85749420 - SANOVEL

Information

• Trademark
• 85749420

• Source

• Serial Number

  85749420

• Registration Number

  4438655

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  October 09, 2012
  12 years ago

• Registration Date

  November 26, 2013
  11 years ago

• Transaction Date

  August 11, 2020
  4 years ago

• Status Date

  July 03, 2020
  4 years ago

• Published for Opposition Date

  September 10, 2013
  11 years ago

• Location Date

  November 26, 2013
  11 years ago

• Status Code

  710

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  KEAM, ALEX S

• Attorney Docket Number

  311570.30440

  Attorney Name

  Keith E. Danish

  Law Office Assigned Location Code

  M50

• Owners

  • SANOVEL ILAC SANAYI VE TICARET ANONIM SIRK-ETI

Case File Statements

• CC0000: Color is not claimed as a feature of the mark.
• GS0051: pharmaceutical preparations for the treatment of cardiovascular disorders, skeleto-muscular disorders, general infections, viral infections, central nervous system disorders, gastro-intestinal disorders, fungal diseases, erectile dysfunction, respiratory diseases, allergy, ophthalmic diseases, containing one or more of the following active ingredients - cromolin sodium, amlodipin besylate, alendronate sodium, chlorazepate dipotassium, atropine sulphate, atorvastatin calcium, candesartan cilexetil, ceftriaxone sodium, ephedrine hcl, guaiphenesine, zafirlukast, donepezil hcl, diflunisal, dipyridamole, famotidine, losartan potassium, hydro-chlorothiazide, meloxicam, phenyleprine hcl, fexofenadine hcl, indapamide, sulfisoxazole, clopidogrel, lansoprazole, clarithromycin, flurbiprofen, nimesulide, pantoprazole, paracetamole, pilocarpine hcl, lisinopril, pseudoephedrine hcl, ciprofloxacin hcl, sertraline hcl, cyclopentolate hcl, dihydroergotoxine methansulfonate, terbinafine, timolol maleate, tiamphenicol, azithromycin, tenoxicam, fluconazole, digoxine, tioconazole, dimenhydrinate, quinidine arabogalactane sulphate, quinidine phenylethyl barbiturate, diltiazem hcl, buspirone hcl, amiodarone hcl, trazodone, difluprednate, enoxacin, lactulose, ketorolac, pentoxifylline, vitamin e, chlorhexidine, cetrimide, propyphenazone, caffeine, cetirizine, phenylpropanolamine, zolpidem, bacampicillin hcl, roxithromycin, sultamicillin tosilate, acetylsalicylic acid, ampicillin na, sulbactam na, sildenafil citrate, ambroxol hcl, ribavirin, loratadine, etodolac, omeprazole, oxybutynin chloride, quinidine sulphate, olanzapine, raloxifen, pioglitazone, moxifloxacin, rosiglitazone, sibutramin, carvedilol, montelukast, citalopram, gliclazide, cefaclor, ezetimibe, rofecoxib, quetiapine fumarate, metformin hcl, acarbose, chlorpheniramine maleate, nateglinide, leflunomide, valsartan, cefazolin sodium, diacerein, paroxetine, levofloxacin, levetiracetam, zolmitriptan, glibenclamide, tizanidine, perindopril erbumine, ramipril, ceftazidime, cefuroxime axetyl, thiocolchicoside, acamprosate, acetylcysteine, alpha calcidol, alpha lipoic acid, aripiprazole, atomoxetine, balsalazide disodium, butenafine hcl, calcitriol, carbonyl iron, folic acid, calcium carbonate, magnesium hydroxide, cefdinir, cefepime hcl, cefixime, cefpodoxime proxetil, cefprozil, cephalexine monohydrate, ciclesonide, cilazapril, cilostazol, cinitapride, citicoline, co-enzyme q10, darifenasin, deferiprone, dothiepin, duloxetine, eletriptan, escitalopram, esomeprazole, etoricoxib, felodipine, fenofibrate, ferrous sulphate, zinc sulphate, fluvastatin, frovatriptan, gabapentin, galantamine, gemifloxacin, ginkgo biloba, glimepride, granisetron, ibandronate, irbesartan, iron hydroxide polymaltose, lamivudine, lamotrigine, levetiracetam, letrozole, linezolide, memantine hcl, metoprolol, midodrine, mirtazapine, mizolastine, mosapride citrate dihydrate, mycophenolate mofetil, nebivolol, nefazodone, niacin, nitazoxanide, ondansetron, ornidazole, oxcarbazepine, pimecrolimus, pravastatin, pregabalin, rabeprazol, rebamipide, repaglinide, risedronate, risperidone, rivastigmine, rosuvastatin, saccharomyces boulardii, tacrolimus, tadalafil, tamsulosin hcl, tazaroten, tazobactam sodium, piperacillin sodium, tegaserod, telithromycin, terazocin, teriparatide, tolterodine tartrate, topiramate, trandolapril, trimethazidine, valacyclovir, valproate sodium, venlafaxine, voriconazole, ximelagatran, zaleplon, ziprasidone, zoledronic acid

Case File Event Statements

• 7/3/2020 - 4 years ago

  20 - CANCELLED SEC. 8 (6-YR) Type: C8..

• 11/26/2018 - 6 years ago

  19 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1

• 11/26/2013 - 11 years ago

  18 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 9/10/2013 - 11 years ago

  17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 9/10/2013 - 11 years ago

  16 - PUBLISHED FOR OPPOSITION Type: PUBO

• 8/21/2013 - 11 years ago

  15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 8/7/2013 - 11 years ago

  14 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 8/6/2013 - 11 years ago

  13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 8/6/2013 - 11 years ago

  12 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC

• 8/6/2013 - 11 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/1/2013 - 11 years ago

  10 - PAPER RECEIVED Type: MAIL

• 2/7/2013 - 12 years ago

  9 - COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED Type: CEPE

• 2/6/2013 - 12 years ago

  8 - ASSIGNED TO LIE Type: ALIE

• 2/6/2013 - 12 years ago

  7 - NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Type: GEAN

• 2/6/2013 - 12 years ago

  6 - EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Type: GEAP

• 2/6/2013 - 12 years ago

  5 - EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED Type: CPEA

• 2/6/2013 - 12 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 12/11/2012 - 12 years ago

  3 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 10/16/2012 - 12 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 10/12/2012 - 12 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP